Low-dose NOAC after COVID-19 hospitalization in patients with high thrombotic risk
Educational information
This video was recorded in response to the presentation of the MICHELLE trial at the ESC congress
Faculty
Prof. Verheugt - cardioloog in Amsterdam, The Netherlands.
Disclosures
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: